| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$202,708,978 |
|
|
|
Indirect Value
|
$172,941,055 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-10 |
4 |
B |
$3.75 |
$149,952 |
D/D |
40,000 |
3,687,561 |
2.45 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-01-21 |
4 |
B |
$15.02 |
$150,200 |
I/I |
10,000 |
11,248,178 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-09-23 |
4 |
B |
$5.50 |
$150,442 |
I/I |
27,353 |
16,660,454 |
2.25 |
% |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-02 |
4 |
B |
$0.89 |
$150,731 |
I/I |
169,361 |
2,784,166 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-22 |
4 |
S |
$2.09 |
$151,592 |
I/I |
(72,591) |
10,866,098 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-11 |
4 |
A |
$15.18 |
$151,800 |
I/I |
10,000 |
2,157,023 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2017-12-20 |
4 |
S |
$44.40 |
$155,400 |
D/D |
(3,500) |
3,365,553 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-15 |
4 |
S |
$2.93 |
$156,378 |
I/I |
(53,333) |
545,012 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-24 |
4 |
A |
$15.84 |
$158,400 |
I/I |
10,000 |
13,370,028 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2013-08-20 |
4 |
B |
$1.45 |
$159,518 |
D/D |
110,005 |
7,064,149 |
2.45 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-20 |
4 |
A |
$16.06 |
$160,600 |
I/I |
10,000 |
13,350,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-02-21 |
4/A |
A |
$16.32 |
$163,200 |
I/I |
10,000 |
13,360,028 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-18 |
4 |
B |
$3.94 |
$165,133 |
I/I |
41,912 |
18,737,047 |
2.25 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-19 |
4 |
B |
$16.60 |
$165,954 |
D/D |
10,000 |
3,255,650 |
2.39 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-12 |
4 |
A |
$17.45 |
$174,500 |
I/I |
10,000 |
2,107,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-08-15 |
4 |
B |
$21.35 |
$175,070 |
I/I |
8,200 |
12,514,905 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-08-26 |
4 |
B |
$17.81 |
$178,100 |
I/I |
10,000 |
10,783,173 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-15 |
4 |
A |
$17.89 |
$178,900 |
I/I |
10,000 |
2,127,023 |
0 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-11-18 |
4 |
B |
$6.33 |
$179,502 |
I/I |
28,361 |
6,084,314 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-08-20 |
4 |
A |
$18.00 |
$180,000 |
I/I |
10,000 |
2,147,023 |
0 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-11-12 |
4 |
B |
$0.78 |
$182,764 |
I/I |
234,313 |
5,721,729 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-01-31 |
4 |
A |
$18.48 |
$184,800 |
I/I |
10,000 |
1,974,423 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-12-12 |
4 |
A |
$7.81 |
$185,250 |
D/D |
19,752 |
1,395,209 |
|
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-08-25 |
4 |
B |
$18.56 |
$185,600 |
I/I |
10,000 |
10,773,173 |
2.25 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2018-01-05 |
4 |
S |
$47.02 |
$188,080 |
I/I |
(4,000) |
3,426,053 |
0 |
- |
|
634 Records found
|
|
Page 15 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
